Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive Cpsulitis (HVLA-MET-AC)
14 maj 2026 uppdaterad av: Memoona Saleem, Green International University
COMPARATIVE EFFECTS OF HIGH-VELOCITY LOW-AMPLITUDE (HVLA) THRUST AND MUSCLE ENERGY TECHNIQUE (MET) ON SHOULDER MOBILITY AND PAIN IN PATIENTS WITH ADHESIVE CAPSULITIS
This study compared the effects of High-Velocity Low-Amplitude (HVLA) thrust and Post-Isometric Relaxation Muscle Energy Technique (PIR-MET) on pain and shoulder mobility in patients with adhesive capsulitis.
Sixty-six participants received either HVLA or PIR-MET with conventional physiotherapy for four weeks.
Both treatments improved pain and range of motion, but PIR-MET showed significantly greater improvement, making it a more effective approach for managing frozen shoulder symptoms.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study compared the effectiveness of High-Velocity Low-Amplitude (HVLA) thrust and Post-Isometric Relaxation Muscle Energy Technique (PIR-MET) in treating adhesive capsulitis (frozen shoulder).
Sixty-six patients received either HVLA or PIR-MET along with conventional physiotherapy for four weeks.
Both treatments improved pain and shoulder mobility, but PIR-MET showed significantly better results in reducing pain and increasing range of motion.
The study concluded that PIR-MET is a more effective manual therapy technique for managing adhesive capsulitis and improving patients' functional recovery and quality of life.
Studietyp
Interventionell
Inskrivning (Faktisk)
66
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Principal Investigator
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Participants diagnosed with Stage II or III Adhesive Capsulitis Age between 40 and 65 years Both male and female participants Presence of shoulder pain and restricted range of motion for at least 3 months Limitation of active and passive shoulder movements, particularly external rotation Willingness to participate and provide informed consent Ability to attend treatment sessions for four weeks
Exclusion Criteria:
- History of shoulder fracture, dislocation, or recent trauma Previous shoulder surgery Neurological disorders affecting shoulder function Rheumatoid arthritis or other systemic inflammatory conditions Cervical radiculopathy or referred pain from the cervical spine Rotator cuff tear or severe shoulder instability Malignancy or infection involving the shoulder joint Participants receiving other concurrent shoulder treatments Contraindications to manual therapy or physiotherapy interventions Unwillingness to participate or inability to complete the treatment protocol
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Group A- HVLA Thrust
Participants in this group received high velocity, low amplitude thrust manipulation to the glenohumeral joint.
Treatment was delivered by a trained physical therapist.
The intervention aimed to restore joint mobility and reduce pain in patients diagnosed with adhesive capsulitis.
Sessions were conducted 3 times per week for 12 weeks, in addition to a standardized home exercise program.
|
A manual therapy technique involving a quick, controlled thrust applied to the glenohumeral joint at the end of the available range of motion.
The goal is to improve joint play and mobility.
Each session lasted approximately 10-15 minutes.
The intervention was performed 3 times per week for 12 weeks.
Adverse events were monitored throughout the study.
Andra namn:
|
|
Experimentell: Group-B MET
Participants in this group received muscle energy technique applied to the shoulder muscles to improve range of motion and decrease pain.
The technique involved active contraction of the patient against manual resistance followed by stretching.
Sessions were conducted 3 times per week for 12 weeks, in addition to a standardized home exercise program.
|
An active manual therapy technique where the patient contracts the shoulder muscles against the therapist's resistance, followed by a passive stretch.
Target muscles included the posterior capsule, pectoralis major, and rotator cuff as indicated.
Each session lasted approximately 15-20 minutes.
The intervention was performed 3 times per week for 12 weeks.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Visual Analogue Scale (VAS) for Pain
Tidsram: Baseline and after 4 weeks of intervention
|
Pain intensity was assessed using the Visual Analogue Scale (VAS), a 10 cm scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Participants marked their perceived shoulder pain level before and after the four-week intervention period.
|
Baseline and after 4 weeks of intervention
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
9 november 2025
Primärt slutförande (Faktisk)
29 april 2026
Avslutad studie (Faktisk)
6 maj 2026
Studieregistreringsdatum
Först inskickad
14 maj 2026
Först inskickad som uppfyllde QC-kriterierna
14 maj 2026
Första postat (Faktisk)
20 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
20 maj 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
14 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- GIU/REC/26-24
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
JA
IPD-planbeskrivning
Only IPD used in the result publication will be shared
Tidsram för IPD-delning
It will be available after the completion of study
Kriterier för IPD Sharing Access
De-identified participant data, including demographic details, pain scores, shoulder range-of-motion data, study protocol, and analysis information, will be available to qualified researchers upon reasonable request and approval.
Access will be provided through secure electronic sharing while maintaining participant confidentiality and ethical standards.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .